Ek. Jackson et al., INJURED ERYTHROCYTES RELEASE ADENOSINE-DEAMINASE INTO THE CIRCULATION, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1250-1260
The purpose of this study was to test the hypothesis that circulating
red blood cells (RBCs) release adenosine deaminase (ADA) when injured.
This hypothesis was evaluated in rats using dimethyl sulfoxide (DMSO)
to damage RBCs. Boluses and infusions of DMSO caused a reduction in u
rinary adenosine and a concomitant hemoglobinuria, and the ability of
DMSO to reduce urinary adenosine was blocked by pretreatment with the
ADA inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine. Infusions of DMSO
also significantly enhanced ADA activity in urine and plasma. Dimethyl
sulfone, an analog of DMSO that does not affect RBCs, did not cause he
moglobinuria and did not affect urinary adenosine. High concentrations
of DMSO did not affect adenosine metabolism in rat kidneys perfused w
ithout RBCs, and DMSO did not decrease urinary adenosine in rats rende
red severely anemic (hematocrit <15%) by replacing whole blood with pl
asma. However, DMSO did decrease urinary adenosine in rats without a s
pleen, a major source of adenosine deaminase apart from circulating RB
Cs. DMSO reduced renal interstitial levels of adenosine and attenuated
bradycardic responses to exogenous adenosine, and these effects were
prevented by erythro-9-(2-hydroxy-3-nonyl)adenine. These results indic
ate that circulating damaged RBCs release significant amounts of ADA,
a process that may predispose to vasoocclusive events.